Androgen levels in women with various forms of ovarian dysfunction: Associations with cardiometabolic features

Human Reproduction

Volumn 30, Issue 10, 2015, Pages 2376-2386

  Daan, N M P ^a   Jaspers, L ^b   Koster, M P H ^a   Broekmans, F J M ^a   De Rijke, Y B ^b   Franco, O H ^b   Laven, J S E ^b   Kavousi, M ^b   Fauser, B C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Androgens; Cardiovascular risk factors; Menopause; PCOS; POI

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; STEROID;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FREE ANDROGEN INDEX; HUMAN; INSULIN RESISTANCE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MENSTRUAL CYCLE; METABOLIC PARAMETERS; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PREMATURE OVARIAN FAILURE; SMOKING; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; ENDOCRINE SYSTEM; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

ADULT; ANDROGENS; ANDROSTENEDIONE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; ENDOCRINE SYSTEM; FEMALE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; PRIMARY OVARIAN INSUFFICIENCY; STEROIDS; TANDEM MASS SPECTROMETRY; TESTOSTERONE; YOUNG ADULT;

EID: 84943339835     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev195     Document Type: Article

References (58)

1. Bancroft J, Cawood EH. Androgens and the menopause; a study of 40-60-year-old women. Clin Endocrinol (Oxf) 1996;45:577-587.
2. Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995;311:1193-1196.
3. Bernini GP, Moretti A, Sgro M, Argenio GF, Barlascini CO, Cristofani R, Salvetti A. Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause 2001;8:43-50.
4. Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A et al. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2005; 16:561-572.
5. Britto R, Araujo L, Barbosa I, Silva L. Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants. Gynecol Endocrinol 2012;28:767-769.
6. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210-1217.
7. Burke CW, Anderson DC. Sex-hormone-binding globulin is an oestrogen amplifier. Nature 1972;240:38-40.
8. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591.
9. Castelo-Branco C, Palacios S, Vazquez F, Villero J, Ferrer J, Ascaso C, Balasch J. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study. Fertil Steril 2007;88: 383-389.
10. Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE, Levitz M, Koenig KL. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis 2011;216:414-419.
11. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606.
12. Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril 2014;102:1444-1451.
13. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changeswith age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853.
14. Domanski MJ, Davis BR, PfefferMA, KastantinM, Mitchell GF. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension 1999;34:375-380.
15. Faubion SS, KuhleCL, Shuster LT, RoccaWA. Long-termhealth consequences of premature or early menopause and considerations for management. Climacteric 2015;18:483-491.
16. Fauser BC, Tarlatzis BC, RebarRW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012; 97:28-38. e25.
17. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166-4170.
18. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127:e6-e245.
19. Gooren LJ, WierckxK, Giltay EJ. Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern. Eur J Endocrinol 2014;170:809-819.
20. Handelsman DJ, Wartofsky L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab 2013;98:3971-3973.
21. Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab 2015;100:911-919.
22. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013;28:889-926.
23. Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SA, Yeap BB. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study. J Clin Endocrinol Metab 2012;97:179-189.
24. Iftikhar S, Collazo-Clavell ML, Roger VL, St Sauver J, Brown RD Jr, Cha S, Rhodes DJ. Risk of cardiovascular events in patients with polycystic ovary syndrome. Neth J Med 2012;70:74-80.
25. Janse F, Tanahatoe SJ, Eijkemans MJ, Fauser BC. Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update 2012;18:405-419.
26. Kalantaridou SN, Calis KA, Vanderhoof VH, Bakalov VK, Corrigan EC, Troendle JF, Nelson LM. Testosterone deficiency in young women with 46, XX spontaneous premature ovarian failure. Fertil Steril 2006; 86:1475-1482.
27. Khatibi A, Agardh CD, Shakir YA, Nerbrand C, Nyberg P, Lidfeldt J, Samsioe G. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) study. Climacteric 2007; 10:386-392.
28. Knauff EA, Westerveld HE, Goverde AJ, Eijkemans MJ, Valkenburg O, van Santbrink EJ, Fauser BC, van der Schouw YT. Lipid profile of women with premature ovarian failure. Menopause 2008;15:919-923.
29. Kolovou GD, Kolovou V, Kostakou PM, Mavrogeni S. Body mass index, lipid metabolism and estrogens: their impact on coronary heart disease. Curr Med Chem 2014;21:3455-3465.
30. Laughlin GA, Goodell V, Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab 2010;95:740-747.
31. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 2004;150:161-171.
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
33. Mongraw-Chaffin ML, Anderson CA, Allison MA, Ouyang P, Szklo M, Vaidya D, Woodward M, Hill Golden S. Association between sex hormones and adiposity: qualitative differences in women and men in the Multi-Ethnic Study of Atherosclerosis. J Clin Endocrinol Metab 2015; 100:E596-600.
34. Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab 2012;97:3251-3260.
35. Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, Kopp P, Gapstur SM. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009;204:255-261.
36. Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopause-a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999;78:642-647.
37. Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, Cauley JA, Sutton-Tyrrell K, Robbins J, Fried LP et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009;94:4776-4784.
38. Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W. Androgen generation in adipose tissue in women with simple obesity-a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. J Endocrinol 2004;183:331-342.
39. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 2008;61:67-77.
40. Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003;108:1688-1693.
41. Roeters van Lennep JE, Heida KY, Bots ML, Hoek A, on behalf of the Collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol 2014. pii:2047487314556004. [Epub ahead of print].
42. Rosner W. Plasma steroid-binding proteins. Endocrinol Metab Clin North Am 1991;20:697-720.
43. Rosner W, Vesper H, Endocrine Society, American Association for Clinical Chemistry, American Association of Clinical Endocrinologists, Androgen Excess/PCOS Society, American Society for Bone and Mineral Research, American Society for Reproductive Medicine, American Urological Association, Association of Public Health Laboratorieset al. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab 2010;95:4542-4548.
44. Rotterdam ESHRE/ASRM-Sponsored PCOS ConsensusWorkshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
45. Rozenberg S, Bosson D, Peretz A, Caufriez A, Robyn C. Serum levels of gonadotrophins and steroid hormones in the post-menopause and later life. Maturitas 1988;10:215-224.
46. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsoredWomen's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008;93:1276-1284.
47. Soisson V, Brailly-Tabard S, Helmer C, Rouaud O, Ancelin ML, Zerhouni C, Guiochon-Mantel A, Scarabin PY. A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. Maturitas 2013;75:282-288.
48. Srinath R, Hill Golden S, Carson KA, Dobs A. Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) Study. J Clin Endocrinol Metab 2015;100:1602-1608.
49. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torrens JI et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111:1242-1249.
50. Toulis KA, Goulis DG, Mintziori G, Kintiraki E, Eukarpidis E, Mouratoglou SA, Pavlaki A, Stergianos S, PoulasouchidouM, Tzellos TG et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update 2011;17:741-760.
51. UtzAL, YamamotoA, SlussP, BreuJ, MillerKK. Androgensmaymediatea relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion. J Clin Endocrinol Metab 2008;93:4033-4040.
52. Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH, Laven JS. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 2008;93:470-476.
53. VermeulenA, Verdonck L, KaufmanJM. Acritical evaluationof simplemethods for the estimationof free testosterone in serum. J Clin EndocrinolMetab 1999; 84:3666-3672.
54. Villablanca AC, JayachandranM, Banka C. Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond) 2010;119:493-513.
55. Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009; 6:532-542.
56. WHO. Global Health Observatory (GHO) Data: leading causes of death in females, 2015.
57. Xu L, Freeman G, Cowling BJ, Schooling CM. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 2013;11:108-7015-11-108.
58. Zang H, Carlstrom K, Arner P, Hirschberg AL. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 2006;86:136-144.